and U.S. BANK, N.A., as TrusteeIndenture • February 13th, 2002 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • New York
VOTING AGREEMENTVoting Agreement • December 21st, 2001 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXHIBIT 99.3 AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • October 21st, 1999 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
ARTICLE I THE MERGERAgreement and Plan of Merger • February 20th, 1997 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Exhibit 10.35 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (the "Agreement"), made this 14th day of October, 1999, is entered into by Millennium Pharmaceuticals, Inc., a Delaware corporation with its principal place of business...Executive Employment Agreement • February 25th, 2000 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Exhibit 10.6 THIRD AMENDMENT TO LEASE THIS THIRD AMENDMENT TO LEASE ("Amendment") is made as of the 12th day of June, 1996 by and between MASSACHUSETTS INSTITUTE OF TECHNOLOGY, a Massachusetts educational corporation with an address of 238 Main...Lease • February 25th, 2000 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
1 EXHIBIT 10.44 MASTER AGREEMENTMaster Agreement • March 31st, 1997 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Exhibit 10.29 MILLENNIUM PHARMACEUTICALS, INC. 5.50% CONVERTIBLE SUBORDINATED NOTES DUE JANUARY 15, 2007 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 25th, 2000 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • New York
RECITALSRegistration Rights Agreement • November 16th, 1998 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXHIBIT 1.1 MILLENNIUM PHARMACEUTICALS, INC. Common Stock, par value $0.001 ---------------------- UNDERWRITING AGREEMENTUnderwriting Agreement • October 6th, 2000 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • New York
BY AND BETWEENSupply Agreement • November 8th, 2005 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • New York
LEASEMillennium Pharmaceuticals Inc • November 13th, 1996 • Pharmaceutical preparations
CONFIDENTIAL ATTORNEY-CLIENT PRIVILEGED DOCUMENT RIGHTS AGREEMENTRights Agreement • April 5th, 2001 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
1 EXHIBIT 10.2 INVESTMENT AGREEMENT dated as of September 22, 1998 by and betweenInvestment Agreement • November 16th, 1998 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.11 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT--EXCLUSIVEAgreement • March 10th, 2004 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • District of Columbia
EXHIBIT 10.2 ADDENDUM NO. 4 TO MASTER LEASE AGREEMENT DATED AS OF SEPTEMBER 19, 1996 THIS ADDENDUM (this "Addendum") amends and supplements the above referenced lease (the "Lease"), between General Electric Capital Corporation ("Lessor") and...Master Lease Agreement • March 15th, 2001 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations
FIRST AMENDED AND RESTATED AGREEMENT OF LIMITED PARTNERSHIP OF L & I PARTNERS, L.P.Millennium Pharmaceuticals Inc • March 15th, 2001 • Pharmaceutical preparations • Delaware
SUPPLEMENTAL AGREEMENT relating to the Licence Agreement made between the same parties dated 31(st) March 1997 THIS DEED made the 19(th) day of May 1998 between (1) BRITISH TECHNOLOGY GROUP LIMITED whose company registration number is 2664412 and...Supplemental Agreement • March 15th, 2001 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations
LEASELease • August 12th, 1998 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations
LEASE -----Millennium Pharmaceuticals Inc • May 15th, 1997 • Pharmaceutical preparations • Massachusetts
ISSUER, TOIndenture • February 25th, 2000 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • New York
a) The LESSOR fails to give written notice within thirty (30) days of intention to restore leased premises, or (b) The LESSOR fails to restore the leased premises to a condition substantially suitable for their intended use within ninety (90) days of...Millennium Pharmaceuticals Inc • March 31st, 1997 • Pharmaceutical preparations
MILLENNIUM PHARMACEUTICALS, INC. Issuer ANDIndenture • August 1st, 2000 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • New York
b) Subject to the terms and conditions of this Agreement, PerSeptive further grants to ChemGenics an exclusive, irrevocable, worldwide, royalty free fully paid right and license, terminable only as set forth in Section 9.3, to all PerSeptive Patent...License Agreement • March 31st, 1997 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
BETWEENDevelopment and License Agreement • August 3rd, 2001 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
and U.S. BANK, N.A., as TrusteeSupplemental Indenture • February 13th, 2002 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • New York
1 Exhibit 10.57 SIXTH AMENDMENT TO LEASE THIS SIXTH AMENDMENT TO LEASE ("Amendment") is made as of the 29th day of January, 1999 by and between MASSACHUSETTS INSTITUTE OF TECHNOLOGY, a Massachusetts educational corporation with an address of 238 Main...Millennium Pharmaceuticals Inc • March 24th, 1999 • Pharmaceutical preparations • Massachusetts
AMENDMENT NO. 1 TO COLLABORATIVE RESEARCH AGREEMENT AND LICENSE OPTION, LICENSE AND ROYALTY AGREEMENT EACH DATED AS OF JANUARY 1, 1995Royalty Agreement • March 24th, 1999 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations
INTRODUCTIONCollaboration and License Agreement • October 25th, 2001 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.41 Each of the following executive officers of the Company has entered into a stock restriction agreement on substantially the terms set forth in the stock restriction agreement attached hereto on the dates set forth below:Stock Restriction Agreement • March 15th, 2001 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
EXHIBIT NO. 10.9 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. NEW LONG TERM SUPPLY AGREEMENT This New Long Term Supply Agreement (the "Agreement") is entered into as of...License and Supply Agreement • March 7th, 2003 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • England
1 Exhibit 10.51 AMENDMENT, CONSENT AND WAIVER ----------------------------- This Amendment, Consent and Waiver (this "Waiver"), dated as of January 18, 1997, by and among American Home Products Corporation Acting Through Its Wyeth- Ayerst Laboratories...Consent And • March 31st, 1997 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations
and U.S. BANK, N.A., as TrusteeSupplemental Indenture • February 13th, 2002 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • New York
BY AND BETWEENTechnology Transfer Agreement • July 26th, 2000 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
1 EXHIBIT 10.48 CONFIDENTIALITY AND NON-COMPETITION AGREEMENT THIS CONFIDENTIALITY AND NON-COMPETITION AGREEMENT (this "Agreement") is made and entered into as of the 28th day of June, 1996 by and between ChemGenics Pharmaceuticals Inc., a Delaware...Confidentiality and Non-Competition Agreement • March 31st, 1997 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
